Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy

OBJECTIVE: The primary aim was to determine the safety of treatment with human immune globulin 10% with recombinant human hyaluronidase (fSCIg) compared to intravenous immunoglobulin (IVIg) in a prospective open-label study in patients with multifocal motor neuropathy (MMN). METHODS: Our study consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Herraets, Ingrid J. T., Bakers, Jaap N. E., van Eijk, Ruben P. A., Goedee, H. Stephan, van der Pol, W. Ludo, van den Berg, Leonard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803588/
https://www.ncbi.nlm.nih.gov/pubmed/31325017
http://dx.doi.org/10.1007/s00415-019-09475-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803588/
https://www.ncbi.nlm.nih.gov/pubmed/31325017
http://dx.doi.org/10.1007/s00415-019-09475-x

Ejemplares similares